Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
3
51
Ṁ111Ṁ90
2030
84%
chance
1D
1W
1M
ALL
1: The market resolves as "Yes" if the U.S. Food and Drug Administration (FDA) grants full or conditional approval for THIO-101 as a treatment for advanced Non-Small Cell Lung Cancer by the specified date.
2: The market resolves as "No" if the FDA explicitly rejects the application for THIO-101 for the mentioned indication by the specified date.
3: If neither approval nor rejection is announced by the FDA by the specified date, the market will resolve as "No."
Context: https://www.businesswire.com/news/home/20231024406334/en/
Get Ṁ200 play money
Related questions
Will the FDA approve a disease-modifying treatment for Parkinson's disease before 2029?
59% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
38% chance
Will an AI-designed drug get FDA approval by the end of 2025?
33% chance
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
28% chance
Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?
76% chance
Will a cancer therapy approved by the FDA before 2027 successfully cure >1 cancer type?
63% chance
Will there be an FDA approved cure for Parkinson's Disease by EOY 2032?
50% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against myeloid leukemia before 2028?
28% chance